Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Therapy for High-risk pN0 Thoracic Esophageal Squamous Cell Carcinoma
NCT02891083Phase 3Unknown
- Sponsor
- Shanghai Chest Hospital
- Start
- Jan 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, cisplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Shanghai Chest Hospital. Status: unknown.
02
Drugs
paclitaxelcisplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02891083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02891083.